Disclosure Statement Pursuant to the Pink Basic Disclosure Guidelines

Rafina Innovations, Inc..

9 Karpenisiou, Strovolos Lefkosias 2021, Cyprus

646 300 9438

www.Rafina-Innovations.com email: info@rafinainnovations.com

SIC code:3841

Quarterly Report June 30, 2022

(the "Reporting Period")

As of the quarter ended June 30, 2022, the number of shares outstanding of our Common Stock was: 122,022,796

As of the year ended December 31, 2021, the number of shares outstanding of our Common Stock was: 122,022,796

As of the Year Ended December 31, 2020, the number of shares outstanding of our Common Stock was: 30,388,596

Indicate by check mark whether the company is a shell company (as defined in Rule 405 of the Securities Act of 1933 and Rule 12b-2 of the Exchange Act of 1934):

Yes:

No:

Indicate by check mark whether the company's shell status has changed since the previous reporting period:

Yes:

No:

Indicate by check mark whether a Change in Control1 of the company has occurred over this reporting period:

Yes:

No:

  • "Change in Control" shall mean any events resulting in:
  1. Any "person" (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) becoming the "beneficial owner" (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the total voting power represented by the Company's then outstanding voting securities;
  2. The consummation of the sale or disposition by the Company of all or substantially all of the Company's assets;
  3. A change in the composition of the Board occurring within a two (2)-year period, as a result of which fewer than a majority of the directors are directors immediately prior to such change; or
  4. The consummation of a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or its parent) at least fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity or its parent outstanding immediately after such merger or consolidation.

OTC Markets Group Inc.

1

OTC Pink Basic Disclosure Guidelines (v3.1 June 24, 2021)

  1. Name and address(es) of the issuer and its predecessors (if any)

In answering this item, provide the current name of the issuer any names used by predecessor entities, along with the dates of the name changes.

Rafina Innovations, Inc.

The state of incorporation or registration of the issuer and of each of its predecessors (if any) during the past five years; Please also include the issuer's current standing in its state of incorporation (e.g. active, default, inactive):

Nevada (Active) incorporated on March 26, 2007.

Describe any trading suspension orders issued by the SEC concerning the issuer or its predecessors since inception:

None

List any stock split, stock dividend, recapitalization, merger, acquisition, spin-off, or reorganization either currently anticipated or that occurred within the past 12 months:

None

The address(es) of the issuer's principal executive office:

9 Karpenisiou, Strovolos Lefkosias 2021, Cyprus

The address(es) of the issuer's principal place of business:

Check box if principal executive office and principal place of business are the same address:

NA

Has the issuer or any of its predecessors been in bankruptcy, receivership, or any similar proceeding in the past five years?

Yes:

No:

If this issuer or any of its predecessors have been the subject of such proceedings, please provide additional details in the space below:

NA

OTC Markets Group Inc.

2

OTC Pink Basic Disclosure Guidelines (v3.1 June 24, 2021)

2) Security Information

Trading symbol:

VICA

Exact title and class ofsecurities outstanding:

Common

CUSIP

75063R106

Par or stated value

$.001

Total shares authorized:

750,000,000 as of date:June 30, 2022

Total shares outstanding:

122,022,796 as of date: June 30, 2022

Number of shares in the Public Float6

26,793,384 as of date June 30, 2022

Total Preferred shares authorized:

20,000,000 shares (Par $.001) as of date June 30, 2022

Total Number of Shareholders of record

98 as of June 30, 2022

Transfer Agent

Name:

Action Stock Transfer Corp.

Address:

2469 Fort Union Blvd STE 214, Cottonwood Heights, UT 84121

Phone:

801-274-1088

Email:

Info@actionstocktransfer.com

Is the Transfer Agent registered under the Exchange Act?7

Yes: NO

  • "Public Float" shall mean the total number of unrestricted shares not held directly or indirectly by an officer, director, any person who is the beneficial owner of more than 10 percent of the total shares outstanding (a "control person"), or any affiliates thereof, or any immediate family members of officers, directors and control persons.
  • To be included in the Pink Current Information tier, the transfer agent must be registered under the Exchange Act.

OTC Markets Group Inc.

3

OTC Pink Basic Disclosure Guidelines (v3.1 June 24, 2021)

3) Issuance History -

The goal of this section is to provide disclosure with respect to each event that resulted in any direct changes to the total shares outstanding of any class of the issuer's securities in the past two completed fiscal years and any subsequent interim period.

Disclosure under this item shall include, in chronological order, all offerings and issuances of securities, including debt convertible into equity securities, whether private or public, and all shares, or any other securities or options to acquire such securities, issued for services. Using the tabular format below, please describe these events.

A. Changes to the Number of Outstanding Shares -

Check this box to indicate there were no changes to the number of outstanding shares within the past two completed fiscal years and any subsequent periods: :

Number of Shares as of 1/1/19 Opening

*Right-click the rows below and select "Insert" to

Balance:

add rows as needed.

Common.17,469,681

Preferred: 0

Date of

Transaction

Number of

Class

Value of

Were the

Individual/ Entity Shares

Reason for

Restricted or

Exemption or

Transaction

type (e.g. new

Shares Issued (or

of

shares

shares issued

were issued to (entities

share

Unrestricted

Registration

issuance,

cance17lled)

Securi

issued

at a discount

must have individual with

issuance

as of this

Type.

cancellation,

ties

($/per

to market

voting / investment

(e.g. for

filing.

shares

share) at

price at the

control disclosed).

cash or

returned to

Issuance

time of

debt

conversion)

treasury)

issuance?

-OR-

(Yes/No)

Nature of

Services

Provided

Services

05/06/2020

New

754,899

CS

.06

No

Nikolaos Ioannou

rendered

R

4(a)(2)

Services

10/23/2020

New

2,000,000

CS

.06

No

Alkis Aloneftis

rendered

R

4(a)(2)

Services

10/23/2020

New

3,000,000

CS

.06

No

Nikitas Dimitropoulos

rendered

S

?(a)(2)

Services

10/23/2020

New

500,000

CS

.06

No

Dimitrios Gemenis

rendered

S

4(a)(2)

Services

10/23/2020

New

404,218

CS

.06

No

Georgios Grigoriadis

rendered

S

4(a)(2)

OTC Markets Group Inc.

4

OTC Pink Basic Disclosure Guidelines (v3.1 June 24, 2021)

Services

10/23/2020

New

100,000

CS

.06

No

Daivis Ilias

rendered

R

4(a)(2)

Services

10/23/2020

New

3,000,000

CS

.06

No

Theodoros Papoulias

rendered

R

4(a)(2)

Services

10/23/2020

New

2,000,000

CS

.06

No

Damianos Varelis

rendered

R

4(a)(2)

Services

10/23/2020

New

159,798

CS

.06

No

Veloudo Christina Velissar

rendered

S

4(a)(2)

.06

No

Private

02/02/2021

New

507,500

CS

Veng Tech Solutions

Offering

S

4(a)(2)

.06

No

Debt

2/3/2021

New

2,500,000

CS

Dimitrios Gemenis

Settlement

BR

4(a)(2)

.06

No

Debt

2/3/2021

New

1,575,700

CS

Nikolaos Ioannou

Settlement

BS

4(a)(2)

No

Debt

3/10/2021

New

1,600,000

CS

.06

Djessy Huiszoon

Settlement

S

4(a)(2)

.06

No

Debt

3/10/2021

New

1,600,000

CS

Simon Jost

Settlement

S

4(a)(2)

.06

No

Debt

3/10/2021

New

1,600,000

CS

Franziska Jost

Settlement

S

4(a)(2)

.06

No

Debt

3/10/2021

New

1,600,000

CS

Gerrit Reede

Settlement

S

4(a)(2)

.06

No

Debt

3/10/2021

New

10,067,700

CS

Stella Thrapsanioti

Settlement

SC

4(a)(2)

.06

No

Debt

3/10/2021

New

10,067,700

CS

Georgios Thrapsaniotis

Settlement

SC

4(a)(2)

.06

No

Debt

3/11/2021

New

3,200,000

CS

Dimitrios Kontogiorgos

Settlement

B

4(a)(2)

04/16/2021

New

1,000,000

CS

.01

No

Konstantinos Sokos

Service

S

4(a)(2)

No

Gcc S.R.L. Global Capital

Connections

04/19/2021

New

500,000

CS

.01

CP: Kostas Sommer

Services

S

4(a)(2)

04/19/2021

New

10,000,000

CS

.01

No

Konstantinos Katsikas

Acquisition

SC

4(a)(2)

New

CS

.01

No

Pertineo Investments Limited

04/19/2021

500,000

CP: Dimitrios Orfanos

Services

S

4(a)(2)

OTC Markets Group Inc.

5

OTC Pink Basic Disclosure Guidelines (v3.1 June 24, 2021)

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

HCi VioCare published this content on 19 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 19 August 2022 20:53:53 UTC.